Denali Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNLI research report →
About the company
Denali Therapeutics Inc. is a biopharmaceutical firm, founded in 2013 and based in South San Francisco, California, which focuses on identifying and advancing treatments for neurodegenerative conditions within the United States. The company, initially known as SPR Pharma Inc.
- CEO
- Ryan J. Watts
- IPO
- 2017
- Employees
- 443
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $4.10B
- P/E
- -8.97
- P/S
- 0.00
- P/B
- 5.21
- EV/EBITDA
- -7.60
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -52.20%
- ROIC
- -46.93%
- Revenue
- $0 · 0.00%
- Net Income
- $-512,540,000 · -21.23%
- EPS
- $-2.97 · -15.56%
- Op Income
- $-555,342,000
- FCF YoY
- -16.09%
- 52W High
- $26.80
- 52W Low
- $12.58
- 50D MA
- $20.91
- 200D MA
- $18.84
- Beta
- 1.01
- Avg Volume
- 1.80M
Get TickerSpark's AI analysis on DNLI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | FLATLEY JAY T | other | 6,408 |
| Jun 3, 26 | FLATLEY JAY T | other | 19,226 |
| Jun 3, 26 | Klein Peter S | other | 6,408 |
| Jun 3, 26 | Klein Peter S | other | 19,226 |
| Jun 3, 26 | Krognes Steve E. | other | 6,408 |
| Jun 3, 26 | Krognes Steve E. | other | 19,226 |
| Jun 3, 26 | Schenkein David P | other | 6,408 |
| Jun 3, 26 | Schenkein David P | other | 19,226 |
| Jun 3, 26 | Thornberry Nancy | other | 6,408 |
| Jun 3, 26 | Thornberry Nancy | other | 19,226 |
Our DNLI coverage
Recent articles, reports, and earnings notes.
No research on DNLI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DNLI report →Similar companies
Peers in the same neighborhood.